Volume 77, Issue 8

Search all European Journal of Clinical Pharmacology articles

August 2021

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Incidence risk of PD-1/PD-L1–related pneumonia and diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis of randomized controlled trials
Zhi-Qiang Tong
Dong-Yuan Wu
Mei Dong
Review 10 February 2021 Pages: 1079 - 1088
The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
Chia Siang Kow
Syed Shahzad Hasan
Review 02 February 2021 Pages: 1089 - 1094
Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes
Tingyu Wang
Yitian Zhou
Guosheng Cao
Review 29 January 2021 Pages: 1095 - 1111
Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review
Elizabeth Sierocinski
Felix Holzinger
Jean-François Chenot
Review Open access 01 February 2021 Pages: 1113 - 1122
Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review
Suresh Kumar Srinivasamurthy
Ramkumar Ashokkumar
Uppugunduri Satyanarayana Chakradhara Rao
Review Open access 23 February 2021 Pages: 1123 - 1131
The comparative impact among different intensive statins and combination therapies with niacin/ezetimibe on carotid intima-media thickness: a systematic review, traditional meta-analysis, and network meta-analysis of randomized controlled trials
Hongwei Li
Xiaolin Xu
Yuling Zhang
Review 18 February 2021 Pages: 1133 - 1145
Research on Beers Criteria and STOPP/START Criteria based on the FDA FAERS database
Qianqian Shao
Yulong Xu
Wei Liu
Pharmacodynamics 25 June 2021 Pages: 1147 - 1156
Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition
Chie Emoto
Trevor N. Johnson
Tsuyoshi Fukuda
Pharmacokinetics and Disposition 01 February 2021 Pages: 1157 - 1168
Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration
Marta Ulldemolins
Carla Bastida
Dolors Soy
Pharmacokinetics and Disposition 09 February 2021 Pages: 1169 - 1180
Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers
M. E. Otto
K. R. Bergmann
Michiel J. van Esdonk
Pharmacokinetics and Disposition Open access 11 February 2021 Pages: 1181 - 1192
In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates
Tim Preijers
Laura Bukkems
Ron Mathôt
Pharmacokinetics and Disposition Open access 24 February 2021 Pages: 1193 - 1200
Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients
Marit Tveito
Gudrun Høiseth
Robert Løvsletten Smith
Pharmacokinetics and Disposition 22 February 2021 Pages: 1201 - 1208
EurOP²E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers
Michiel J. Bakkum
Milan C. Richir
for the Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP)
Pharmacoepidemiology and Prescription Open access 23 February 2021 Pages: 1209 - 1218
The impact of health literacy on beliefs about medication in a Dutch medication-using population
B. B. (Boudewijn) Visscher
B. (Bas) Steunenberg
J. (Jany) Rademakers
Pharmacoepidemiology and Prescription 16 February 2021 Pages: 1219 - 1224
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
Giulia Bonaldo
Nicola Montanaro
Domenico Motola
Pharmacoepidemiology and Prescription Open access 20 February 2021 Pages: 1225 - 1234
Construction and analysis of a database for medication errors in a pharmacovigilance centre—the Moroccan experience
Loubna Alj
Raja Benkirane
Rachida Soulaymani Bencheikh
Pharmacoepidemiology and Prescription 17 February 2021 Pages: 1235 - 1246
Proposal of a Tall Man Letter list for German-speaking countries
Johannes Heck
Adrian Groh
Olaf Krause
Letter to the Editor Open access 27 January 2021 Pages: 1247 - 1249
Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome
Hongxia Liu
Qinxia Xu
Xiaoyan Qiu
Correction 30 January 2021 Pages: 1251 - 1252
Correction to: Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria
Lorena de Agustín Sierra
Jaime Rodríguez Salazar
Benito García Díaz
Correction 04 February 2021 Pages: 1253 - 1253
Correction to: Iron chelation may harm patients with COVID-19
Michael D. Garrick
Andrew J. Ghio
Correction 17 March 2021 Pages: 1255 - 1255
Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
Stefanie Fekete
K. Egberts
M. Gerlach
Correction Open access 28 May 2021 Pages: 1257 - 1257

Volume 77, Issue 8

Incidence risk of PD-1/PD-L1–related pneumonia and diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis of randomized controlled trials

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes

Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review

Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review

The comparative impact among different intensive statins and combination therapies with niacin/ezetimibe on carotid intima-media thickness: a systematic review, traditional meta-analysis, and network meta-analysis of randomized controlled trials

Research on Beers Criteria and STOPP/START Criteria based on the FDA FAERS database

Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition

Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration

Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers

In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates

Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients

EurOP²E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers

The impact of health literacy on beliefs about medication in a Dutch medication-using population

Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice

Construction and analysis of a database for medication errors in a pharmacovigilance centre—the Moroccan experience

Proposal of a Tall Man Letter list for German-speaking countries

Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome

Correction to: Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria

Correction to: Iron chelation may harm patients with COVID-19

Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride

Navigation